David K Williams

This inventor holds 30 USPTO granted patents and 2 published patent applications and 7 EPO patents, primarily in Immunotherapy Agents. Top assignees: Bristol-Myers Squibb Compnay, Flexus Biosciences, Inc., Syngene International Limited. Active years: 2004-2025.

USPTO Granted Patents = 30 (Patent Applications = 2)

% Patents Active = 96.7

EPO Patents = 7 (Patent Applications = 17)

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 77(Granted Patents)

Location History:

San Antonio, TX (US) (2007)
Delran, NJ (US) (2004 - 2024)
Princeton, NJ (US) (2020 - 2024)

Company Filing History:

21 out of 3,736

Bristol-Myers Squibb Compnay

patents

7 out of 8

Flexus Biosciences, Inc.

patents

4 out of 7

Syngene International Limited

patents

4. 3 out of 21

Innate Tumor Immunity, Inc.

patents

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

Areas of Expertise:

NLRP3 Modulators

IDO Inhibitors

Immunoregulatory Agents

Cancer Treatment

Met Kinase Inhibitors

IAP Antagonists

Cyano-Substituted Compounds

Indoleamine 2,3-Dioxygenase

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391675 - NLRP3 modulators (2025-08-19),

2. 12171756 - NLRP3 modulators (2024-12-24),

3. 12145927 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2024-11-19),

4. 12059420 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2024-08-13),

5. 11932601 - Immunoregulatory agents (2024-03-19),

6. 11649212 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2023-05-16),

7. 11447449 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2022-09-20),

8. 11344543 - NLRP3 modulators (2022-05-31),

9. 11242319 - Immunoregulatory agents (2022-02-08),

10. 11066392 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2021-07-20),

11. 11066383 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2021-07-20),

12. 10696648 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2020-06-30),

13. 10689331 - IDO inhibitors (2020-06-23),

14. 10633342 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2020-04-28),

15. 10544099 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2020-01-28),

Title: The Innovative Journey of David K Williams

Introduction: David K Williams, a pioneering inventor hailing from Delran, New Jersey, has made significant contributions to the world of innovations and patents.

Latest Patents: David K Williams has recently been granted patents for cutting-edge technologies in the fields of renewable energy, artificial intelligence, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, David K Williams has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing groundbreaking solutions. His patents have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, David K Williams has collaborated with leading research institutions, universities, and innovative companies to bring his inventions to life. His ability to work across disciplines and industries has led to the creation of truly innovative products.

Conclusion: In conclusion, David K Williams stands as a testament to the power of innovation and perseverance in the world of inventing. His passion for pushing the boundaries of what is possible has led to numerous patents that have shaped the future of technology.